EcoDrugPlus

Mapk Activated Protein Kinase 2

Ensembl ID : ENSOPRG00000011311
Gene Symbol: MAPKAPK2
1 Cross references
233 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 1

Ensembl ID : ENSOPRG00000017297
Gene Symbol: MKNK1
1 Cross references
167 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSOPRG00000009677
Gene Symbol: MDM2
1 Cross references
258 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSOPRG00000000875
Gene Symbol: MET
1 Cross references
211 Possible Orthologues:

Mpl Proto-Oncogene, Thrombopoietin Receptor

Ensembl ID : ENSOPRG00000016124
Gene Symbol: MPL
1 Cross references
186 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSOPRG00000006429
Gene Symbol: MLST8
1 Cross references
201 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSOPRG00000013934
Gene Symbol: NFE2L2
1 Cross references
216 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSOPRG00000005200
Gene Symbol: NPC1L1
3 Cross references
189 Possible Orthologues:

Rar Related Orphan Receptor C

Ensembl ID : ENSOPRG00000018310
Gene Symbol: RORC
1 Cross references
382 Possible Orthologues:

Ros Proto-Oncogene 1, Receptor Tyrosine Kinase

Ensembl ID : ENSOPRG00000015334
Gene Symbol: ROS1
1 Cross references
124 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSOPRG00000003522
Gene Symbol: RAF1
3 Cross references
216 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSOPRG00000012428
Gene Symbol: SRC
3 Cross references
262 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).